Difference between revisions of "Osteopontin (TG2)"
(New page: {{subst:infobox}}) |
m |
||
| (5 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | Osteopontin |
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | - | + | | Bone sialoprotein-1 |
| + | Uropontin | ||
|- | |- | ||
| Determination type | | Determination type | ||
| − | | In situ | + | | In situ/In vitro |
|- | |- | ||
| Source | | Source | ||
| Line 18: | Line 16: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | | + | | Extracellular; mineralized compartment of bone |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| − | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P10451 P10451 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | | + | | Q34, Q36 |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| Line 30: | Line 28: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | | + | | NPDPS''Q''K''Q''NLLAP |
|- | |- | ||
| Structure | | Structure | ||
| − | | | + | | No available crystal structure |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 42: | Line 40: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=7998923&dopt=Abstract PMID:7998923] |
| + | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=12469910&dopt=Abstract PMID:12469910] | ||
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | Crosslinking of osteopontin by TG2 incrases it's binding to collagen |
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:50, 10 March 2015
| Osteopontin (TG2) | |
|---|---|
| Substrate peptide name | Osteopontin |
| Synonyms | Bone sialoprotein-1
Uropontin |
| Determination type | In situ/In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; mineralized compartment of bone |
| Swissprot ID | P10451 |
| Reactive glutamines | Q34, Q36 |
| Reactive lysines | Not determined yet |
| Substrate sequence | NPDPSQKQNLLAP |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:7998923 |
| Notes | Crosslinking of osteopontin by TG2 incrases it's binding to collagen |
